2012
DOI: 10.1016/j.rec.2012.03.008
|View full text |Cite
|
Sign up to set email alerts
|

In-hospital Acquired Anemia in Acute Coronary Syndrome. Predictors, In-hospital Prognosis and One-year Mortality

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
10
0

Year Published

2013
2013
2018
2018

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(12 citation statements)
references
References 37 publications
2
10
0
Order By: Relevance
“…Others have similarly shown that HAA is common among patients hospitalized with AMI and is associated with greater mortality. 5,9,18 Our study extends upon this prior research by showing that severe HAA increases the risk for adverse outcomes for all adult inpatients, not only those hospitalized for AMI or among those receiving blood transfusions.…”
Section: Discussionsupporting
confidence: 71%
“…Others have similarly shown that HAA is common among patients hospitalized with AMI and is associated with greater mortality. 5,9,18 Our study extends upon this prior research by showing that severe HAA increases the risk for adverse outcomes for all adult inpatients, not only those hospitalized for AMI or among those receiving blood transfusions.…”
Section: Discussionsupporting
confidence: 71%
“…It is obvious that patients after AMI with anemia have greater cardiovascular risk [1][2][3][4][5][6], whereas in patients without anemia at admission the risk stratification remains equivocal. Easy and cheap parameters that would help in a better determination of prognosis are needed.…”
Section: Introductionmentioning
confidence: 99%
“…In addition to the cost of the test itself, overutilization also leads to increased phlebotomy, which can lead to patient discomfort and hospital-acquired anemia. In turn, hospital-acquired anemia has been associated with increased blood transfusions, length of stay, and mortality (2)(3)(4)(5)(6). Furthermore, the results of laboratory tests must be reviewed by the clinician and can trigger additional downstream tests and interventions, each of which carries costs and risks.…”
mentioning
confidence: 99%